ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,199Medicare Part D Prescriptions Filled, Including Refills

Rank: 146 out of 1206

$554K Total Retail Price of All Prescriptions

Rank: 119 out of 1206

500 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 500 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 500 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,153 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 568 530 1 1
LEVOTHYROXINE SODIUM 405 394 2 2
AMLODIPINE BESYLATE 328 324 3 6
HYDROCODONE-ACETAMINOPHEN 327 303 S3 4 7
OMEPRAZOLE 320 310 5 3
WARFARIN SODIUM 309 267 6 8
FUROSEMIDE 303 285 7 5
HYDROCHLOROTHIAZIDE 296 295 8 11
LISINOPRIL 287 276 9 4
ATORVASTATIN CALCIUM 262 251 10 13
METOPROLOL SUCCINATE 244 244 11 15
ATENOLOL 237 221 12 14
METFORMIN HCL 225 212 13 10
FINASTERIDE 182 169 14 90
CITALOPRAM HBR 175 138 15 16
METOPROLOL TARTRATE 156 154 16 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 149 17 27
TAMSULOSIN HCL 144 140 18 26
POTASSIUM CHLORIDE 140 117 19 12
ALLOPURINOL 139 120 20 24
PREDNISONE 128 114 21 28
TRAMADOL HCL 128 101 21 17
JANUVIA 123 104 23 87
LOSARTAN-HYDROCHLOROTHIAZIDE 117 116 24 60
GABAPENTIN 109 83 25 18
GLIMEPIRIDE 103 95 26 34
ALENDRONATE SODIUM 98 98 27 19
MIRTAZAPINE 97 97 28 50
POLYETHYLENE GLYCOL 3350 96 95 29 31
LOSARTAN POTASSIUM 92 84 30 20
DIOVAN HCT 87 87 31 112
AMITRIPTYLINE HCL 86 73 R 32 59
FAMOTIDINE 85 83 33 65
CRESTOR 83 76 34 30
AMLODIPINE BESYLATE-BENAZEPRIL 83 83 34 76
ZOLPIDEM TARTRATE 80 67 36 25
FENTANYL 77 62 S2 37 51
VENLAFAXINE HCL ER 76 76 38 89
ISOSORBIDE MONONITRATE ER 72 72 39 40
TERAZOSIN HCL 69 69 40 81
DONEPEZIL HCL 68 61 41 29
MELOXICAM 66 60 42 35
SERTRALINE HCL 65 43 43 22
LANTUS SOLOSTAR 64 52 44 85
DIOVAN 63 63 45 57
CARBIDOPA-LEVODOPA 61 45 46 70
PEN NEEDLE 57 49 47 121
ATENOLOL-CHLORTHALIDONE 57 57 47 170
BISOPROLOL FUMARATE 55 55 49 202
METFORMIN HCL ER 55 54 49 58
RANITIDINE HCL 54 43 51 23
PROMETHAZINE HCL 52 0 R 52 215
PAROXETINE HCL 51 35 53 53
FLUTICASONE PROPIONATE 50 46 54 42
KLOR-CON M20 50 50 54 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.